Literature DB >> 12961063

The implication of assessing a polymorphism in estrogen receptor alpha gene in the risk assessment of osteoporosis using a screening tool for osteoporosis in Asians.

Boonsong Ongphiphadhanakul1, Suwannee Chanprasertyothin, Penpan Payattikul, Sunee Saetung, Rajata Rajatanavin.   

Abstract

Both genetic and environmental factors interact to determine bone mass and the risk for developing postmenopausal osteoporosis. Recently, an Asian-specific tool, the Osteoporosis Self-Assessment Tool for Asians (OSTA), has been developed to assess the risk of osteoporosis in women. An index is calculated by multiplying the difference in body weight in kilograms and age in years by 0.2 and disregarding the decimal digits. The risk of osteoporosis is classified as high, intermediate or low according to the OSTA index less than -4, -4 to -1 and greater than -1. In the present study we examined how a single nucleotide polymorphism (SNP) in exon 8 of the estrogen receptor alpha (ERalpha) gene affected the predictive value of the OSTA index. Subjects consisted of 358 postmenopausal women who were at least 55 years old. BMDs were measured by DXA, and the SNP in the ERalpha gene was assessed by PCR-RFLP. When considering both the OSTA index and ERalpha genotype in a logistic regression model, it was found that both the OSTA index and the ERalpha genotype independently contributed to the risk of osteoporosis. The odds ratios were 1.58 (95% CI 1.26-1.91) and 2.51 (95% CI 1.42-4.44) for one unit decrement in the OSTA index and each copy of the A allele of the ERalpha genotype, respectively. The joint effect conformed more to a multiplicative model of interaction than an additive model. This suggests that persons with the high-risk genotype are at far greater risk of developing osteoporosis with advancing age or decreasing body weight, the two variables from which the OSTA index is derived. Targeting preventive measures for osteoporosis subjects with risk factors and also disease-susceptibility alleles is likely to be more cost effective.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12961063     DOI: 10.1007/s00198-003-1464-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  19 in total

Review 1.  Genetics of osteoporosis.

Authors:  J A Eisman
Journal:  Endocr Rev       Date:  1999-12       Impact factor: 19.871

2.  Two new single-nucleotide polymorphisms in the COL1A1 upstream regulatory region and their relationship to bone mineral density.

Authors:  Natalia Garcia-Giralt; Xavier Nogués; Anna Enjuanes; Jordi Puig; Leonardo Mellibovsky; Anne Bay-Jensen; Ramon Carreras; Susana Balcells; Adolfo Díez-Pérez; Daniel Grinberg
Journal:  J Bone Miner Res       Date:  2002-03       Impact factor: 6.741

3.  Vertebral fractures in Beijing, China: the Beijing Osteoporosis Project.

Authors:  X Ling; S R Cummings; Q Mingwei; Z Xihe; C Xioashu; M Nevitt; K Stone
Journal:  J Bone Miner Res       Date:  2000-10       Impact factor: 6.741

Review 4.  Effect modification and the limits of biological inference from epidemiologic data.

Authors:  W D Thompson
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

5.  Familial resemblance for bone mineral mass is expressed before puberty.

Authors:  S Ferrari; R Rizzoli; D Slosman; J P Bonjour
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

6.  Association of a G2014A transition in exon 8 of the estrogen receptor-alpha gene with postmenopausal osteoporosis.

Authors:  B Ongphiphadhanakul; S Chanprasertyothin; P Payattikul; S Saetung; N Piaseu; L Chailurkit; R Rajatanavin
Journal:  Osteoporos Int       Date:  2001-12       Impact factor: 4.507

7.  Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in a sample of white women from Belgium.

Authors:  W Ben Sedrine; J P Devogelaer; J M Kaufman; S Goemaere; G Depresseux; B Zegels; R Deroisy; J Y Reginster
Journal:  Bone       Date:  2001-10       Impact factor: 4.398

8.  Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene.

Authors:  S F Grant; D M Reid; G Blake; R Herd; I Fogelman; S H Ralston
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

9.  Prediction of bone density from vitamin D receptor alleles.

Authors:  N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

Review 10.  Genetic control of susceptibility to osteoporosis.

Authors:  Stuart H Ralston
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

View more
  5 in total

Review 1.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

Review 2.  Performance of the Osteoporosis Self-Assessment Tool in ruling out low bone mineral density in postmenopausal women: a systematic review.

Authors:  B Rud; J Hilden; L Hyldstrup; A Hróbjartsson
Journal:  Osteoporos Int       Date:  2007-03-15       Impact factor: 4.507

3.  IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women.

Authors:  Jian-min Liu; Hong-yan Zhao; Guang Ning; Ying Chen; Lian-zhen Zhang; Li-hao Sun; Yong-ju Zhao; Man-yin Xu; Jia-lun Chen
Journal:  J Bone Miner Metab       Date:  2008-02-27       Impact factor: 2.626

4.  Coffee consumption and bone mineral density in korean premenopausal women.

Authors:  Eun-Joo Choi; Kyae-Hyung Kim; Young-Jin Koh; Jee-Sun Lee; Dong-Ryul Lee; Sang Min Park
Journal:  Korean J Fam Med       Date:  2014-01-23

Review 5.  Associations between ERα/β gene polymorphisms and osteoporosis susceptibility and bone mineral density in postmenopausal women: a systematic review and meta-analysis.

Authors:  Heping Zhu; Jiannong Jiang; Qiang Wang; Jun Zong; Liang Zhang; Tieliang Ma; Youjia Xu; Leiyan Zhang
Journal:  BMC Endocr Disord       Date:  2018-02-20       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.